Cardiotoxicity of adjuvant chemotherapy with trastuzumab: a Japanese claim-based data analysis
Objective Adjuvant chemotherapy with trastuzumab improves the postoperative life expectancy of women with early-stage breast cancer. Although trastuzumab is reportedly cardiotoxic, quantification based on real-world evidence is lacking. Therefore, in this study, we aimed to analyse trastuzumab cardi...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-08-01
|
| Series: | Open Heart |
| Online Access: | https://openheart.bmj.com/content/9/2/e002053.full |